CYBB and Alzheimer disease: In addition, inhibiting the activation of NOX2 with ginsenoside Rg1 could improve cognitive impairments, protect neurons from damage, and lower the deposition of amyloid beta in mice modeling Alzheimer’s disease (AD) (Zhang et al., 2021).